3M stock absorbs $5.8 billion PFAS charge as guidance holds

Published on 11/13/2026 at 12:52 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

3M stock faces a broad PFAS settlement covering most current personal-injury claims. The company kept its 2026 guidance unchanged despite the legal charge.

Settlement limits legal uncertainty

The agreement addresses approximately 99% of current PFAS personal-injury claims involving as many as 120,000 eligible plaintiffs.
Payments are spread through 2034, with no scheduled payment in 2027 and most installments due later in the program.
3M said the settlement charge will be treated as a special item and will not change its previously issued 2026 guidance.

3M Company, US88579Y1010, Illustration mit AI erstellt.

3M entered a broad resolution of PFAS-related personal-injury claims on Tuesday, November 3, 2026, covering litigation in the federal Aqueous Film-Forming Foam multidistrict case in South Carolina. In its press release, 3M said the agreement is intended to resolve approximately 99% of current personal-injury claims inside and outside the litigation.

The company will make a pre-tax nominal commitment of $7.35 billion over nine years. Its present value is $5.8 billion, which 3M plans to record as a pre-tax charge in the fourth quarter of 2026. The charge will be treated as a special item in adjusted results rather than included in the company's adjusted performance measures.

Payments extend through 2034

The agreement covers an estimated 115,000 to 120,000 eligible plaintiffs. It includes a $50 million payment in 2026 and no scheduled payment in 2027. Approximately 20% of the payments fall in the final two years, while a $680 million reserve fund forms part of the overall commitment for remaining and future claims.

Participation thresholds remain relevant to the settlement. 3M said the agreement is not an admission of liability and that it is prepared to continue defending the litigation if agreed conditions are not fulfilled. The company also said it ended global PFAS manufacturing by the end of 2025 and will continue remediation at sites where it historically produced the compounds.

Guidance remains unchanged

3M said the settlement does not change its previously issued 2026 guidance. Chief Executive William Brown described the agreement as a significant milestone that substantially reduces litigation uncertainty, while management linked the payment structure to the company's other legacy obligations and cash-flow planning.

For investors, the settlement removes a major legal overhang but adds a substantial special charge to reported fourth-quarter earnings. The long payment schedule limits the immediate cash requirement, while participation levels and future claims remain conditions to monitor. The unchanged guidance means the company continues to frame the charge as separate from its operating outlook.

3M stock traded at 168.63 euros on Lang & Schwarz at 12:47 CET on Friday, November 13, 2026, 1.04 percent below the Xetra close of Thursday, November 12. The comparison uses the Xetra close of 170.40 euros.